Array BioPharma (ARRY) Reports Encouraging Data from MEK162 in Ongoing Phase 2

Go back to Array BioPharma (ARRY) Reports Encouraging Data from MEK162 in Ongoing Phase 2
Array Biopharma, Inc. (NASDAQ: ARRY) Delayed: 4.92 --0 (-0%)
Previous Close $4.92    52 Week High $7.27 
Open $4.92    52 Week Low $2.39 
Day High $4.92    P/E N/A 
Day Low $4.92    EPS $-0.61 
Volume 7,486